Sunesis Pharmaceuticals Company Profile (NASDAQ:SNSS)

About Sunesis Pharmaceuticals

Sunesis Pharmaceuticals logoSunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia (AML). Vosaroxin is an anticancer quinolone derivative (AQD). The Company's other kinase inhibitor pipeline include TAK-580, SNS-062 and SNS-229. TAK-580 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors. SNS-062 is a non-covalently binding inhibitor of Bruton's tyrosine kinase (BTK). The Company has completed the pre-clinical studies for SNS-062. SNS-229 and SNS-510 are two PDK1 inhibitors. PDK1 is a kinase and mediator of Phosphoinositide 3-kinase/AKT (PI3K/AKT) signaling, which is a pathway involved in cell growth, differentiation, survival and migration.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SNSS
  • CUSIP: 86732860
Key Metrics:
  • Previous Close: $0.88
  • 50 Day Moving Average: $0.63
  • 200 Day Moving Average: $0.58
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.87
  • P/E Growth: -0.02
  • Market Cap: $76.57M
  • Outstanding Shares: 87,014,000
  • Beta: 1.92
Additional Links:
Companies Related to Sunesis Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Sunesis Pharmaceuticals (NASDAQ:SNSS) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: N/A

Analysts' Ratings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
DateFirmActionRatingPrice TargetDetails
7/29/2016Cowen and CompanyReiterated RatingMarket PerformView Rating Details
7/29/2016Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details
5/6/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
7/24/2015Roth CapitalDowngradeBuy -> Sell$5.50 -> $1.00View Rating Details
7/2/2015WedbushReiterated RatingHold$2.00View Rating Details
1/6/2015BTIG ResearchInitiated CoverageBuy$5.50View Rating Details
10/6/2014Royal Bank Of CanadaDowngradeOutperform -> Sector Perform$9.00 -> $3.00View Rating Details
(Data available from 8/29/2014 forward)


Earnings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/29/2016Q216($0.10)($0.12)$0.70 million$0.60 millionViewListenView Earnings Details
5/5/2016Q116($0.12)($0.12)$0.77 million$0.64 millionViewListenView Earnings Details
3/10/2016Q415($0.14)($0.15)$0.84 million$0.67 millionViewListenView Earnings Details
11/5/2015Q315($0.12)($0.09)$1.09 million$0.68 millionViewListenView Earnings Details
7/30/2015Q215($0.13)($0.15)$1.21 million$0.85 millionViewN/AView Earnings Details
5/5/2015Q115($0.16)($0.13)$1.14 million$0.90 millionViewListenView Earnings Details
3/12/2015Q414($0.20)($0.02)$1.17 million$0.90 millionViewListenView Earnings Details
11/10/2014Q314($0.17)($0.25)$1.97 million$0.85 millionViewListenView Earnings Details
8/5/2014Q214($0.17)($0.20)$1.32 million$2.00 millionViewListenView Earnings Details
5/7/2014Q114($0.17)($0.26)$1.32 million$2.00 millionViewListenView Earnings Details
3/6/2014Q413($0.20)($0.15)$1.37 million$2.00 millionViewListenView Earnings Details
11/12/2013Q313($0.20)($0.16)$1.44 million$1.99 millionViewListenView Earnings Details
7/29/2013Q2 2013($0.21)$0.18$1.22 million$1.99 millionViewListenView Earnings Details
5/9/2013Q1 2013($0.20)($0.23)$0.75 million$1.99 millionViewListenView Earnings Details
3/13/2013Q4 2012($0.19)($0.20)$0.32 million$1.99 millionViewListenView Earnings Details
11/8/2012Q312($0.11)($0.37)$4.17 million$0.26 millionViewN/AView Earnings Details
8/9/2012($0.20)($0.20)ViewN/AView Earnings Details
5/15/2012($0.18)($0.30)ViewN/AView Earnings Details
11/14/2011($0.18)($0.11)ViewN/AView Earnings Details
8/11/2011($0.15)($0.18)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Current Year EPS Consensus Estimate: $-0.45 EPS
Next Year EPS Consensus Estimate: $-0.47 EPS


Dividend History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2016Geoffrey M ParkerDirectorBuy9,500$0.47$4,465.00View SEC Filing  
5/25/2016Geoffrey M ParkerDirectorBuy52,505$0.47$24,677.35View SEC Filing  
12/21/2015Dayton MisfeldtDirectorBuy1,750,000$0.84$1,470,000.00View SEC Filing  
8/25/2015Daniel N Swisher JrCEOBuy12,216$1.01$12,338.16View SEC Filing  
8/24/2015Daniel N Swisher JrCEOBuy12,784$1.01$12,911.84View SEC Filing  
8/29/2014Forest BaskettMajor ShareholderSell266,700$7.97$2,125,599.00View SEC Filing  
8/28/2014Bay City Capital LlcMajor ShareholderSell300,700$7.98$2,399,586.00View SEC Filing  
8/28/2014Dayton MisfeldtDirectorSell200,000$7.89$1,578,000.00View SEC Filing  
8/27/2014Adam R CraigCMOSell2,554$8.00$20,432.00View SEC Filing  
8/27/2014Daniel N Swisher JrCEOSell5,000$8.00$40,000.00View SEC Filing  
8/27/2014Dayton MisfeldtDirectorSell100,700$8.16$821,712.00View SEC Filing  
8/27/2014Eric BjerkholtCFOSell10,000$8.00$80,000.00View SEC Filing  
8/27/2014Krishna Kittu KolluriMajor ShareholderSell108,300$8.17$884,811.00View SEC Filing  
8/12/2014Dayton MisfeldtDirectorSell743,700$6.64$4,938,168.00View SEC Filing  
8/12/2014Equity Opportunities Fu GrowthMajor ShareholderSell710,540$6.63$4,710,880.20View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Sunesis Pharmaceuticals (NASDAQ:SNSS)
News Icon$ESV & $SNSS - ENSCO PLC (NYSE:ESV) & Sunesis Pharmaceuticals, (NASDAQ:SNSS) Intraday Movers - Money News (press release) (NASDAQ:SNSS) - August 29 at 7:19 PM logoSunesis Announces Publication in "Drugs" Detailing Molecular and Pharmacologic Properties of Vosaroxin (NASDAQ:SNSS) - August 25 at 12:35 PM logoWill Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Hit $2.5 Price Target? - Investor Newswire (NASDAQ:SNSS) - August 19 at 10:25 AM
News IconSunesis Pharmaceuticals, Inc.'s (SNSS): Stock's Report of the Thursday - Hot Stocks Point (NASDAQ:SNSS) - August 19 at 10:25 AM logoETF’s with exposure to Sunesis Pharmaceuticals, Inc. : August 18, 2016 (NASDAQ:SNSS) - August 18 at 7:45 PM
News IconTrading the Biotech News: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), ContraVir Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:SNSS) - August 18 at 10:35 AM logoSunesis Pharmaceuticals (SNSS) Jumps: Stock Rises 23.1% (NASDAQ:SNSS) - August 18 at 10:35 AM logoSUNESIS PHARMACEUTICALS INC Financials (NASDAQ:SNSS) - August 5 at 7:44 PM logoETF’s with exposure to Sunesis Pharmaceuticals, Inc. : August 4, 2016 (NASDAQ:SNSS) - August 4 at 7:58 PM logoSunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:SNSS) - August 3 at 7:53 PM
News IconUpbeat Biotech Stocks- Sunesis Pharmaceuticals (NASDAQ:SNSS), CytRx Corporation (NASDAQ:CYTR) - Seneca Globe (NASDAQ:SNSS) - August 2 at 12:28 PM
News IconTechnical Evaluation For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - The Voice Registrar (NASDAQ:SNSS) - August 2 at 12:28 PM
News IconDoes Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) Have Sufficient Cash To Remain Afloat? - Scibility Media (NASDAQ:SNSS) - August 2 at 12:28 PM logoSunesis Pharmaceuticals Inc. (SNSS) Jumps 7.56% on August 01 - (NASDAQ:SNSS) - August 1 at 7:17 PM logoEdited Transcript of SNSS earnings conference call or presentation 29-Jul-16 3:00pm GMT (NASDAQ:SNSS) - August 1 at 7:16 PM
News IconBeatable Stocks in Active Notes- Alphabet (NASDAQ:GOOG), Sunesis Pharmaceuticals (NASDAQ:SNSS), Wellesley ... - Seneca Globe (NASDAQ:SNSS) - August 1 at 12:08 PM
News IconHC Stocks Newsbeat: Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - share market updates (press release) (NASDAQ:SNSS) - August 1 at 12:08 PM logoTraders Recap: Sunesis Pharmaceuticals, Inc. (SNSS), CSX Corp. (CSX), Eclipse Resources Corporation (ECR) - iStreetWire (NASDAQ:SNSS) - August 1 at 12:08 PM
News IconUnited Parcel Service, (NYSE:UPS) & Sunesis Pharmaceuticals, (NASDAQ:SNSS) Stock's Buzzers - Money News (press release) (NASDAQ:SNSS) - August 1 at 12:08 PM logoCowen Comments on Sunesis Pharmaceuticals, Inc. (SNSS) Following 2Q:16 Update - Smarter Analyst (NASDAQ:SNSS) - July 31 at 11:20 AM logoSunesis Pharmaceuticals Inc. (SNSS) Jumps 28.44% on July 29 - (NASDAQ:SNSS) - July 30 at 10:14 AM logo7:04 am Sunesis Pharma misses by $0.02, misses on revs (NASDAQ:SNSS) - July 30 at 7:04 AM logoSunesis Pharmaceuticals Inc.: Sunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results and Recent Highlights (NASDAQ:SNSS) - July 29 at 7:41 PM logoSunesis Pharmaceuticals Reports Second Quarter 2016 Financial Results and Recent Highlights (NASDAQ:SNSS) - July 29 at 10:35 AM logoSunesis Pharmaceuticals : reports 2Q loss (NASDAQ:SNSS) - July 29 at 10:35 AM logoSunesis reports 2Q loss (NASDAQ:SNSS) - July 29 at 9:18 AM
News IconStock Moving Lower for the Month; Investor Update on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Engelwood Daily (NASDAQ:SNSS) - July 22 at 10:24 AM
News IconSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:SNSS) - July 22 at 10:24 AM logoIs $2.5 Price Target Attainable For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)? - Investor Newswire (NASDAQ:SNSS) - July 22 at 10:24 AM
News IconEquity Roundup: Stock Performance Focus on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Press Telegraph (NASDAQ:SNSS) - July 22 at 10:24 AM logoSunesis Pharmaceuticals Inc (NASDAQ:SNSS) Stock Technicals at Critical Inflection Point - CML News (NASDAQ:SNSS) - July 22 at 10:24 AM
News IconInsiders Increasing Positions in: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Press Telegraph (NASDAQ:SNSS) - July 21 at 10:19 AM logoSunesis to Host Conference Call on July 29th to Discuss Second Quarter 2016 Financial Results and Recent Highlights (NASDAQ:SNSS) - July 21 at 7:00 AM logoOption Market: Sunesis Pharmaceuticals Inc Risk Hits An Extreme High - CML News (NASDAQ:SNSS) - July 18 at 12:40 PM
News IconShares Moving Down on the Week: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Engelwood Daily (NASDAQ:SNSS) - July 17 at 11:31 AM logoStrong Sell Calls For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) At 0 - Investor Newswire (NASDAQ:SNSS) - July 15 at 6:28 PM
News IconTrading Performance and Target Watch for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Press Telegraph (NASDAQ:SNSS) - July 14 at 11:07 AM
News IconSunesis Pharmaceuticals, Inc. Forms Double Bottom; Strong Momentum for Sellers - Consumer Eagle (NASDAQ:SNSS) - July 13 at 7:54 PM
News IconSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:SNSS) - July 13 at 10:23 AM logoSunesis Pharmaceuticals, Inc. (SNSS) Updated Price Targets - FTSE News (NASDAQ:SNSS) - July 12 at 11:52 AM
News IconHow Many Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)'s Analysts Are Bullish? - Engelwood Daily (NASDAQ:SNSS) - July 9 at 6:49 PM logoBrokers Issue Average Price Target Of 2.12 On Sunesis Pharmaceuticals, Inc. (SNSS) - Fiscal Standard (NASDAQ:SNSS) - July 9 at 6:49 PM logoSunesis Pharmaceuticals Inc. Realized Volatility Hits Extreme Level - CML News (NASDAQ:SNSS) - July 9 at 6:49 PM
News IconCan Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:SNSS) - July 8 at 7:28 PM
News IconCompany Stock Focus for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS): Which Way Will Shares Head? - Press Telegraph (NASDAQ:SNSS) - July 8 at 10:21 AM logoIs $2.5 Within Reach For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)? - Investor Newswire (NASDAQ:SNSS) - July 8 at 10:21 AM
News IconSunesis Pharmaceuticals (SNSS) : Analyst Rating Update - TheFounders Daily (NASDAQ:SNSS) - July 7 at 7:34 PM logoSunesis Pharmaceuticals, Inc. (SNSS) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:SNSS) - July 5 at 7:09 PM logoSunesis Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:SNSS) - July 5 at 8:01 AM
News IconHow Many Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)'s Analysts Are Bearish? - Press Telegraph (NASDAQ:SNSS) - July 2 at 10:06 AM


Sunesis Pharmaceuticals (NASDAQ:SNSS) Chart for Monday, August, 29, 2016

Last Updated on 8/29/2016 by Staff